1. Home
  2. KLTOW vs TUSK Comparison

KLTOW vs TUSK Comparison

Compare KLTOW & TUSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • TUSK
  • Stock Information
  • Founded
  • KLTOW N/A
  • TUSK 2014
  • Country
  • KLTOW United States
  • TUSK United States
  • Employees
  • KLTOW 3
  • TUSK N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • TUSK Oilfield Services/Equipment
  • Sector
  • KLTOW Health Care
  • TUSK Energy
  • Exchange
  • KLTOW Nasdaq
  • TUSK Nasdaq
  • Market Cap
  • KLTOW N/A
  • TUSK 138.6M
  • IPO Year
  • KLTOW 2022
  • TUSK 2016
  • Fundamental
  • Price
  • KLTOW $0.25
  • TUSK $2.68
  • Analyst Decision
  • KLTOW
  • TUSK
  • Analyst Count
  • KLTOW 0
  • TUSK 0
  • Target Price
  • KLTOW N/A
  • TUSK N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • TUSK 118.4K
  • Earning Date
  • KLTOW N/A
  • TUSK 08-08-2025
  • Dividend Yield
  • KLTOW N/A
  • TUSK N/A
  • EPS Growth
  • KLTOW N/A
  • TUSK N/A
  • EPS
  • KLTOW N/A
  • TUSK N/A
  • Revenue
  • KLTOW N/A
  • TUSK $207,208,000.00
  • Revenue This Year
  • KLTOW N/A
  • TUSK N/A
  • Revenue Next Year
  • KLTOW N/A
  • TUSK $28.22
  • P/E Ratio
  • KLTOW N/A
  • TUSK N/A
  • Revenue Growth
  • KLTOW N/A
  • TUSK N/A
  • 52 Week Low
  • KLTOW N/A
  • TUSK $1.68
  • 52 Week High
  • KLTOW N/A
  • TUSK $4.94
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • TUSK 45.69
  • Support Level
  • KLTOW N/A
  • TUSK $2.63
  • Resistance Level
  • KLTOW N/A
  • TUSK $2.72
  • Average True Range (ATR)
  • KLTOW 0.00
  • TUSK 0.11
  • MACD
  • KLTOW 0.00
  • TUSK -0.04
  • Stochastic Oscillator
  • KLTOW 0.00
  • TUSK 10.31

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

Share on Social Networks: